Avanos Medical authorizes $25M share repurchase program

AVANOS MEDICAL, INC.

Board approved $25M one-year share repurchase program on July 28, 2023.
Repurchases allowed on open market or privately, at management's discretion.
Program will not begin until at least one trading day after release of any material non-public info.
Company not obligated to repurchase any amount; program may be suspended or discontinued.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.